Open AccessClinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients
Author(s) -
Gansheng Xie,
Gang Li,
Li Yu,
Jinxian Pu,
Yuhua Huang,
Jinhu Li,
Huming Yin
Publication year - 2019
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000506
Subject(s) - medicine , prostate cancer , fibrinogen , bone metastasis , prostate , metastasis , prostate specific antigen , cancer , receiver operating characteristic , retrospective cohort study , oncology , radiology , gastroenterology , urology
Due to the different treatments for low-volume metastatic prostate cancer (PCa) as well as high-volume ones, evaluation of bone metastatic status is clinically significant. In this study, we evaluated the correlation between pre-treatment plasma fibrinogen and the burden of bone metastasis in newly diagnosed PCa patients.